Suspended
A Pilot Study of the Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Oral Chelated Zinc Supplement
What is being tested
15 mg Chelate zinc supplement
+ Placebo drug supplement
Drug
Who is being recruted
Hair Diseases+4
+ Hypotrichosis
+ Skin Diseases
Over 18 Years
+6 Eligibility Criteria
How is the trial designed
Treatment Study
Placebo-ControlledPhase 1 & 2
Interventional
Study Start: January 2012
Summary
Principal SponsorSiriraj Hospital
Study ContactRattapon Thuangtong, MDMore contacts
Last updated: August 10, 2012Sourced from a government-validated database.Claim as a partner
Study start date: January 1, 2012
Actual date on which the first participant was enrolled.5%minoxidil solution is standard treatment for Female pattern hair loss (FPHL) patient. We gave 15mg chelate Zinc / Placebo drug to patient as an additional trace element. Then measure growth of hair by Global photograph, Microscope hair count, micrometer and record case and side effect during 10 months of treatment.
Principal SponsorSiriraj Hospital
Study ContactRattapon Thuangtong, MDMore contacts
Last updated: August 10, 2012Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Female
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Hair DiseasesHypotrichosisSkin DiseasesPathological Conditions, Signs and SymptomsSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalAlopecia
Criteria
1 inclusion criteria required to participate
Female Pattern Hair Loss ( Ludwig classification grade 1 and 2 )
5 exclusion criteria prevent from participating
Diet control
On supplement diet within 3 month prior to trial
Pregnancy or lactation
Psychologic disorder trichotillomania
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
Experimental15mg Chelate zinc suppliment : additional to standard 5% minoxidil
Group II
PlaceboPlacebo drug to compare with 15mg chelated Zn : additional to standard 5% minoxidil
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Recruiting
SuspendedOne Study Center